The long-term goal of the Division of Cancer Epidemiology and Prevention is to integrate traditional epidemiologic methods with the ever-advancing molecular and omic techniques in cancer research to identify risk factors molecular markers that may serve as tools for cancer prediction, early detection, and prevention. We conduct cancer epidemiology and prevention research in several areas. Learn more below.
Lifang Hou, MD, PhD is a cancer molecular epidemiologist. Her overarching research goal is to understand the biological mechanisms linking environmental risk factors with subclinical or clinical disease development, which ultimately lead to the development of effective strategies for prevention of chronic diseases. The biomarkers that Dr. Hou has investigated include genetic factors (i.e., polymorphisms, telomere length shortening, and mitochondria DNA copy number variations); and epigenetic factors (i.e., DNA methylation, histone modifications, and microRNA profiling). In addition to being a PI of several NIH-funded grants, Dr. Hou is the co-director and co-PI of the Northwestern Consortium for Early Phase Cancer Prevention Trials of the Division of Cancer Prevention (DCP) Consortia, National Cancer Institute. In addition, molecular cancer epidemiology also serves as an useful tool by other areas of our cancer-related epidemiology research, such as environmental, behavioral, nutritional studies.
Elizabeth Hibler, MPH, PhD is a molecular epidemiologist conducting research focused on the relationships between diet, physical activity, and genetic/epigenetic factors in the etiology and prevention of cancer. Dr. Hibler has a background studying vitamin D metabolites and colorectal neoplasia. Dr. Hibler is currently conducting studies related to physical activity and DNA methylation of gene loci associated with breast and colon cancer risk. In the future, her goal is to evaluate the influence of physical activity and dietary interventions on epigenetic variation among individuals at high-risk for cancer.
Linda Van Horn, PhD, RD is a nutritional epidemiologist. In Dr. Van Horn’s Maternal-Offspring Metabolics: Family Intervention Trial (MOMFIT), an NIH-funded (NIDDK-NHLBI-NICHD) Randomized Clinical Trial (RCT) aiming at controlling gestational weight gain (GWG) and maternal-offspring cardiometabolic outcomes among 300 overweight/obese pregnant women by lifestyle interventions (including physical activity consisting of 30 minutes per day of walking and a healthier, nutrient-dense and low-caloric diet), Dr. Hou and Dr. Van Horn study whether maternal toxic trace elements and essential trace elements are associated with the size and body composition of the offspring at birth and in infancy, which are known to be risk factors for childhood and adulthood obesity, a risk factor itself for various cancers.
Raymond Bergan, MD and Dr. Hou have been developing a collaborative project to study dietary genistein intake, blood genistein levels, and epigenetics in prostate cancer in both Chinese and US men. US men have a very high prostate cancer incidence rate, whereas Chinese men have the lowest incidence and mortality rates in the world. This comparative study will provide information for the first time on the role dietary genistein and its biology and epigenetics play in the US-China prostate cancer incidence and mortality rate disparity.
Assistant or Associate Professor in Cancer Population Science, Department of Preventive Medicine and Robert H. Lurie Cancer Center, Northwestern University, Feinberg School of Medicine
The Division of Cancer Epidemiology and Prevention in the Department of Preventive Medicine (DPM) together with the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, seeks an excellent population researcher with a strong line of research in cancer, particularly with a focus on multiple myeloma. This is a full time position on the tenure-eligible track at the rank of assistant or associate professor. DPM and the Lurie Cancer Center jointly provide a rich platform for research including a diverse and broad scientific portfolio of cancer-related studies, biostatistical and health informatics cores, expertise in multi-level assessment methods and technology implementation and collaborative relationships across Northwestern’s biomedical and life sciences campuses. Because an interdisciplinary, collaborative orientation is a defining element of the Department and the Cancer Center, both provide an ideal home for scholars whose work is collaborative, integrative and cuts across traditional content areas.
Faculty in this tenure track position will collaborate on existing projects and will develop an independent research portfolio leading to tenure. This will include: publishing research results in leading peer-reviewed sources; presenting at relevant national conferences; collaborating and consulting with other investigators at Northwestern; teaching graduate-level courses; competing successfully for extramural funding; and participating in departmental and national scientific duties, such as committee membership and peer review of research proposals and publications.
Successful candidates will have an MD, PhD or equivalent. A strong potential to become independently funded is expected of junior candidates. An ability to work in both multidisciplinary teams as well as independently is essential. This full time position is based in the Feinberg School of Medicine at the Chicago lakefront campus. Primary academic appointment will be in the Department of Preventive Medicine.
The Department of Preventive Medicine is comprised of nationally and internationally recognized faculty with expertise in biostatistics, bioinformatics, epidemiology, cancer epidemiology, behavioral medicine, chronic disease prevention, nutrition and exercise. The Cancer Center has an established and dynamic prevention and control program, involving a variety of prevention and control scientists. The Medical School recognizes this as an important area for further development. Successful candidates can anticipate favorable startup package, benefits, and a competitive base salary commensurate with experience. The start date is estimated for September 2017; however, is flexible. Applications will be accepted until the position is filled.
Interested candidates please submit a CV and a statement of research interest to Ms. Julianna Lee (firstname.lastname@example.org), addressed to Lifang Hou, MD, PhD, Associate Professor in Preventive Medicine and Chief, Cancer Epidemiology.
Northwestern University is an Equal Opportunity, Affirmative Action Employer of all protected classes, including veterans and individuals with disabilities. Women, racial and ethnic minorities, individuals with disabilities, and veterans are encouraged to apply. Hiring is contingent upon eligibility to work in the United States.
Lifang Hou, MD, PhD, MS
William Funk, PhD
Wei Zhang, PhD
Jun Wang, PhD
Research Assistant Professor